What are the recommended naproxen dosing guidelines for adults, including regimens for acute pain and chronic inflammatory conditions, and how should the dose be adjusted for elderly patients or those with renal or hepatic impairment?

Naproxen Dosing Guidelines

For acute pain in adults, start with naproxen 500 mg followed by 500 mg every 12 hours or 250 mg every 6-8 hours, with a maximum initial daily dose of 1250 mg and subsequent daily maximum of 1000 mg; for chronic inflammatory conditions like rheumatoid arthritis or osteoarthritis, use 250-500 mg twice daily, and reduce doses in elderly patients and those with renal or hepatic impairment. 1

Standard Adult Dosing by Indication

Acute Pain Conditions (Pain, Dysmenorrhea, Tendonitis, Bursitis)

• Initial dose: 500 mg naproxen, followed by 500 mg every 12 hours OR 250 mg every 6-8 hours 1
• Maximum first day: 1250 mg total 1
• Maximum subsequent days: 1000 mg total daily 1
• Note: Naproxen sodium is preferred for acute conditions due to faster absorption and more rapid onset of pain relief (within 1 hour) 1

Chronic Inflammatory Conditions (Rheumatoid Arthritis, Osteoarthritis, Ankylosing Spondylitis)

• Standard dose: 250 mg, 375 mg, or 500 mg twice daily 1
• Dose flexibility: Morning and evening doses do not need to be equal; more frequent than twice-daily dosing is unnecessary 1
• High-dose option: May increase to 1500 mg/day for limited periods up to 6 months when higher anti-inflammatory activity is required, but only if clinical benefits clearly offset increased risks 1

Acute Gout

• Initial dose: 750 mg naproxen, followed by 250 mg every 8 hours until attack subsides 1

Dose Adjustments for Special Populations

Elderly Patients (≥65 Years)

• Use the lowest effective dose as the unbound plasma fraction of naproxen increases with age, even though total plasma concentration remains unchanged 1
• Caution with high doses: Some dosage adjustment may be required; start low and titrate based on response 1
• Age-based dosing for OTC use: For patients ≥65 years, use 440 mg/day rather than 660 mg/day used in younger adults 2
• Evidence supports safety: Studies show naproxen 375 mg twice daily is well tolerated in elderly patients without clinically meaningful changes in renal or hepatic function 3

Renal Impairment

• Moderate to severe impairment (CrCl <30 mL/min): Naproxen is NOT recommended 1
• Mild impairment: Consider lower starting doses and careful monitoring 1
• Monitoring considerations: Transient increases in serum creatinine may occur with dose escalation but typically resolve within days 4
• Risk factors for nephrotoxicity: Hypovolemia, concomitant use of RAAS inhibitors or diuretics, and elderly age increase risk 5

Hepatic Impairment

• Lower doses recommended in patients with hepatic impairment 1
• Avoid in cirrhosis: NSAIDs should be avoided in cirrhotic patients due to potential hematologic and renal complications 6
• Monitoring: Occasional transient abnormalities in liver function tests may occur but rarely warrant immediate discontinuation 3
• Drug-induced liver injury: While rare, naproxen can cause clinically apparent liver injury, particularly with prolonged high-dose use 7

Critical Safety Considerations

Gastrointestinal Protection

• High-risk patients (age ≥65, history of GI bleeding, concomitant aspirin/warfarin/steroids) should receive naproxen with a proton pump inhibitor 8
• Previous complicated GI event: Use naproxen + PPI or consider COX-2 inhibitor 8
• Risk quantification: One-year GI bleeding risk is 1 in 110 for adults >75 years vs 1 in 2,100 for those <45 years 6

Cardiovascular Considerations

• Mean blood pressure increase: 5 mm Hg with NSAID use 6
• Use with caution in patients with hypertension or congestive heart failure 6
• Avoid in high cardiovascular risk: Consider alternative analgesics in patients at elevated risk for myocardial infarction 6

Duration of Therapy

• Use the lowest effective dose for the shortest duration consistent with treatment goals 1
• Long-term use: Lower daily doses often suffice for chronic administration 1
• Reassess regularly: Adjust dose based on clinical response and adverse events 1

Practical Prescribing Pitfalls

• Formulation differences: Naproxen tablets, suspension, delayed-release tablets, and naproxen sodium tablets are NOT bioequivalent; consider this when changing formulations 1
• Dose conversion: Naproxen sodium 550 mg = naproxen 500 mg 9
• Renal function monitoring: Watch for transient creatinine elevations with dose increases, which typically resolve within 4 days 4
• Avoid in moderate-severe renal disease: This is an absolute contraindication, not just a caution 1
• Drug interactions: NSAIDs with phase 2 metabolism (not naproxen) may be safer in polymedicated elderly patients 10